Literature DB >> 19732008

Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions.

Pascal J Lambert1, Myrna Dyck, Laura H Thompson, Greg W Hammond.   

Abstract

OBJECTIVE: To apply interim surveillance definitions of Clostridium difficile infection (CDI) cases to 1 year of data from the provincewide surveillance system of Manitoba, Canada, to determine the epidemiology of CDI incident cases in a population.
METHODS: CDI cases were categorized with interim surveillance definitions developed by an ad hoc C. difficile surveillance working group. Incident cases recorded in the provincial CDI database between July 2005 and June 2006 were linked to the provincial hospitalization and nursing home databases and analyzed.
RESULTS: One thousand six incident cases were identified over 1 year. Five hundred fifteen (51%) cases were associated with and began in a healthcare facility (HCF), whereas 275 (27%) were associated with and began in the community. An additional 131 (13%) cases were HCF associated but began in the community, while 85 (8%) were of indeterminate origin. Cases of HCF-associated CDI occurred in patients who were older than did cases of community-associated CDI (P < .0001). The provincial rate of community-onset cases was 23.4 per 100,000 person-years, and rates varied among geographic areas. HCF-associated CDI rates among the 10 largest hospitals varied from 0.5 to 8.4 per 10,000 patient-days. The time to CDI onset after hospital admission indicated that 25% of nosocomial cases began by the 8th day, and 50% began by the 17th day.
CONCLUSIONS: Although the majority of CDI cases were associated with exposure to a HCF, 40% of incident CDI began in the community. Populations with HCF- and community-associated CDI demonstrated significantly different age distributions. The wide variation of rates among HCFs requires explanation. The high percentage of incident cases in the community warrants increased study.

Entities:  

Mesh:

Year:  2009        PMID: 19732008     DOI: 10.1086/605719

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  25 in total

1.  Clostridium difficile: Changing Epidemiology, Treatment and Infection Prevention Measures.

Authors:  Jane A Cecil
Journal:  Curr Infect Dis Rep       Date:  2012-12       Impact factor: 3.725

Review 2.  Recent Issues in Pediatric Clostridium difficile Infection.

Authors:  Jason A Clayton; Philip Toltzis
Journal:  Curr Infect Dis Rep       Date:  2017-11-07       Impact factor: 3.725

Review 3.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 4.  Clostridium difficile.

Authors:  Scott Curry
Journal:  Clin Lab Med       Date:  2010-03       Impact factor: 1.935

Review 5.  Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance.

Authors:  Kathleen Mullane
Journal:  Ther Adv Chronic Dis       Date:  2014-03       Impact factor: 5.091

6.  Time trends and predictors of laboratory-confirmed recurrent and severe Clostridioides difficile infections in Manitoba: a population-based study.

Authors:  Seth R Shaffer; Zoann Nugent; Andrew Walkty; B Nancy Yu; Lisa M Lix; Laura E Targownik; Charles N Bernstein; Harminder Singh
Journal:  CMAJ Open       Date:  2020-11-16

7.  Development of a consensus method for culture of Clostridium difficile from meat and its use in a survey of U.S. retail meats.

Authors:  Brandi Limbago; Angela D Thompson; Sharon A Greene; Duncan MacCannell; Charles E MacGowan; Beverly Jolbitado; Henrietta D Hardin; Stephanie R Estes; J Scott Weese; J Glenn Songer; L Hannah Gould
Journal:  Food Microbiol       Date:  2012-08-21       Impact factor: 5.516

8.  A population-based longitudinal study of Clostridium difficile infection-related hospitalization in mid-age and older Australians.

Authors:  Y Chen; K Glass; B Liu; T V Riley; R Korda; M D Kirk
Journal:  Epidemiol Infect       Date:  2016-10-26       Impact factor: 4.434

9.  Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA.

Authors:  Preeta K Kutty; Christopher W Woods; Arlene C Sena; Stephen R Benoit; Susanna Naggie; Joyce Frederick; Sharon Evans; Jeffery Engel; L Clifford McDonald
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

Review 10.  Current status of Clostridium difficile infection epidemiology.

Authors:  Fernanda C Lessa; Carolyn V Gould; L Clifford McDonald
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.